$HGBL
Heritage Global Inc.

2024 Q1 Form 10-K Financial Statement

#000095017024031436 Filed on March 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $12.16M $15.28M $60.55M
YoY Change -26.79% 10.51% 29.06%
Cost Of Revenue $3.891M $4.478M $20.73M
YoY Change -41.71% -13.0% -0.86%
Gross Profit $8.270M $10.81M $39.81M
YoY Change -16.78% 24.44% 53.11%
Gross Profit Margin 68.0% 70.7% 65.76%
Selling, General & Admin $6.358M $6.494M $26.04M
YoY Change 0.92% 1.17% 22.1%
% of Gross Profit 76.88% 60.1% 65.4%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $141.0K $141.0K $100.0K
YoY Change 17.5% 3.68% -81.34%
% of Gross Profit 1.7% 1.3% 0.25%
Operating Expenses $6.358M $6.635M $26.04M
YoY Change 0.92% 1.22% 19.11%
Operating Profit $2.558M $4.171M $14.32M
YoY Change -34.31% 95.91% 245.7%
Interest Expense $695.0K $285.0K $735.0K
YoY Change 124.92% -71.53% -89.29%
% of Operating Profit 27.17% 6.83% 5.13%
Other Income/Expense, Net
YoY Change
Pretax Income $2.466M $4.456M $14.00M
YoY Change -35.55% 42.36% 27.15%
Income Tax $667.0K -$434.0K $1.520M
% Of Pretax Income 27.05% -9.74% 10.86%
Net Earnings $1.799M $4.890M $12.48M
YoY Change -36.41% -50.95% -19.48%
Net Earnings / Revenue 14.79% 31.99% 20.6%
Basic Earnings Per Share $0.05 $0.34
Diluted Earnings Per Share $0.05 $0.13 $0.33
COMMON SHARES
Basic Shares Outstanding 37.16M 37.15M 36.68M
Diluted Shares Outstanding 37.37M 37.59M

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $15.58M $12.28M $12.28M
YoY Change -0.99% -3.06% -3.06%
Cash & Equivalents $15.58M $12.28M $12.28M
Short-Term Investments
Other Short-Term Assets $490.0K $448.0K $448.0K
YoY Change -56.6% -59.75% -59.75%
Inventory $4.735M $5.074M $5.074M
Prepaid Expenses
Receivables $1.558M $1.910M $1.910M
Other Receivables $6.514M $6.581M $6.581M
Total Short-Term Assets $28.87M $26.29M $26.29M
YoY Change -4.26% 10.05% 10.05%
LONG-TERM ASSETS
Property, Plant & Equipment $1.684M $1.705M $4.244M
YoY Change 2.81% -60.78% -2.37%
Goodwill $7.446M $7.446M
YoY Change 0.0% 0.0%
Intangibles $3.655M $3.753M
YoY Change -9.66% -9.44%
Long-Term Investments $20.27M $21.36M $21.36M
YoY Change 52.12% 52.87% 52.87%
Other Assets $64.00K $67.00K $9.182M
YoY Change -13.51% -99.3% -3.48%
Total Long-Term Assets $54.83M $56.88M $56.88M
YoY Change 20.8% 30.25% 30.25%
TOTAL ASSETS
Total Short-Term Assets $28.87M $26.29M $26.29M
Total Long-Term Assets $54.83M $56.88M $56.88M
Total Assets $83.71M $83.17M $83.17M
YoY Change 10.8% 23.1% 23.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.564M $7.237M $1.840M
YoY Change -42.88% -18.9% -79.38%
Accrued Expenses $779.0K $789.0K $6.186M
YoY Change 14.39% 12.23% 779.94%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.765M $1.733M $1.733M
YoY Change -61.05% -49.19% -49.19%
Total Short-Term Liabilities $13.92M $14.73M $14.73M
YoY Change -35.34% -9.2% -9.2%
LONG-TERM LIABILITIES
Long-Term Debt $5.040M $5.495M $5.495M
YoY Change 573.8% 530.88% 530.88%
Other Long-Term Liabilities $1.710M $1.859M $1.859M
YoY Change -15.89% -14.09% -14.09%
Total Long-Term Liabilities $6.750M $7.354M $7.354M
YoY Change 142.72% 142.31% 142.31%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.92M $14.73M $14.73M
Total Long-Term Liabilities $6.750M $7.354M $7.354M
Total Liabilities $20.67M $22.09M $22.09M
YoY Change -14.98% 14.68% 14.68%
SHAREHOLDERS EQUITY
Retained Earnings -$231.2M -$233.0M
YoY Change -4.72% -4.99%
Common Stock $373.0K $372.0K
YoY Change 0.54% 0.81%
Preferred Stock
YoY Change
Treasury Stock (at cost) $794.0K $794.0K
YoY Change 101.01% 101.01%
Treasury Stock Shares
Shareholders Equity $63.03M $61.08M $61.08M
YoY Change
Total Liabilities & Shareholders Equity $83.71M $83.17M $83.17M
YoY Change 10.8% 23.1% 23.1%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income $1.799M $4.890M $12.48M
YoY Change -36.41% -50.95% -19.48%
Depreciation, Depletion And Amortization $141.0K $141.0K $100.0K
YoY Change 17.5% 3.68% -81.34%
Cash From Operating Activities $1.676M $446.0K $13.02M
YoY Change -81.26% -88.6% 100.85%
INVESTING ACTIVITIES
Capital Expenditures $22.00K $20.00K $257.0K
YoY Change -75.28% -83.47% 19.53%
Acquisitions
YoY Change
Other Investing Activities $2.141M -$1.308M -$15.61M
YoY Change -131.97% -88.39% 113.83%
Cash From Investing Activities $2.119M -$1.328M -$15.87M
YoY Change -131.23% -88.34% 111.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $400.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -497.0K -2.417M 2.460M
YoY Change -154.8% -190.9% 3053.85%
NET CHANGE
Cash From Operating Activities 1.676M 446.0K 13.02M
Cash From Investing Activities 2.119M -1.328M -15.87M
Cash From Financing Activities -497.0K -2.417M 2.460M
Net Change In Cash 3.298M -3.299M -388.0K
YoY Change 7.57% -31.48% -59.37%
FREE CASH FLOW
Cash From Operating Activities $1.676M $446.0K $13.02M
Capital Expenditures $22.00K $20.00K $257.0K
Free Cash Flow $1.654M $426.0K $12.76M
YoY Change -81.32% -88.76% 103.64%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0000849145
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-39471
CY2023 dei Entity Registrant Name
EntityRegistrantName
HERITAGE GLOBAL INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
59-2291344
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
12625 High Bluff Drive
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 305
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92130
CY2023 dei City Area Code
CityAreaCode
858
CY2023 dei Local Phone Number
LocalPhoneNumber
847-0659
CY2023 dei Security12b Title
Security12bTitle
Common stock, $0.01 par value
CY2023 dei Trading Symbol
TradingSymbol
HGBL
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
105800000
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
37157616
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023 dei Auditor Firm
AuditorFirmId
1195
CY2023 dei Auditor Name
AuditorName
UHY LLP
CY2023 dei Auditor Location
AuditorLocation
West Des Moines, Iowa
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12279000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12667000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
132000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
122000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1910000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
988000
CY2023Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
650000
CY2022Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
0
CY2023Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
6581000
CY2022Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
4505000
CY2023Q4 us-gaap Inventory Net
InventoryNet
5074000
CY2022Q4 us-gaap Inventory Net
InventoryNet
4619000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
448000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1113000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
26292000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
23892000
CY2023Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
10890000
CY2022Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
4245000
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
21361000
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
13973000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2539000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2776000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1705000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1571000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3753000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4144000
CY2023Q4 us-gaap Goodwill
Goodwill
7446000
CY2022Q4 us-gaap Goodwill
Goodwill
7446000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
9115000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
9449000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
67000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
64000
CY2023Q4 us-gaap Assets
Assets
83168000
CY2022Q4 us-gaap Assets
Assets
67560000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
7237000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
8924000
CY2023Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
4975000
CY2022Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
3188000
CY2023Q4 us-gaap Unsecured Debt Current
UnsecuredDebtCurrent
1733000
CY2022Q4 us-gaap Unsecured Debt Current
UnsecuredDebtCurrent
3411000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
789000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
703000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14734000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16226000
CY2023Q4 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
5495000
CY2022Q4 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
871000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1859000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2164000
CY2023Q4 us-gaap Liabilities
Liabilities
22088000
CY2022Q4 us-gaap Liabilities
Liabilities
19261000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
10.00
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
10.00
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
563
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
563
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
565
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
565
CY2023Q4 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
1000
CY2022Q4 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
1000
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
6000
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
6000
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37157616
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37157616
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36932177
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36932177
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
372000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
369000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
294522000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
293589000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-233026000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-245270000
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
396175
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
243468
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
794000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
395000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
61080000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
48299000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
83168000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
67560000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
60545000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
46914000
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
26040000
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
21326000
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
514000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
536000
CY2023 us-gaap Costs And Expenses
CostsAndExpenses
47285000
CY2022 us-gaap Costs And Expenses
CostsAndExpenses
42772000
CY2023 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1059000
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
6978000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
14319000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
11120000
CY2023 hgbl Interest And Other Expense Net
InterestAndOtherExpenseNet
324000
CY2022 hgbl Interest And Other Expense Net
InterestAndOtherExpenseNet
113000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
13995000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11007000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1520000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4486000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
12475000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
15493000
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36677098
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36016619
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37587308
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37097270
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.34
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
32639000
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
22000
CY2022 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
134000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
406000
CY2022 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
395000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
15493000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
48299000
CY2023 hgbl Cumulative Change In Accounting Principle
CumulativeChangeInAccountingPrinciple
-231000
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9000
CY2023 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
151000
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
776000
CY2023 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
399000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
12475000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
61080000
CY2023 us-gaap Profit Loss
ProfitLoss
12475000
CY2022 us-gaap Profit Loss
ProfitLoss
15493000
CY2023 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
-273000
CY2022 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
279000
CY2023 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1059000
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
6978000
CY2023 us-gaap Other Noncash Expense
OtherNoncashExpense
530000
CY2022 us-gaap Other Noncash Expense
OtherNoncashExpense
0
CY2023 hgbl Noncash Lease Expense
NoncashLeaseExpense
642000
CY2022 hgbl Noncash Lease Expense
NoncashLeaseExpense
548000
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
514000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
536000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
418000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4961000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
776000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
540000
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
931000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1744000
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
455000
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1399000
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-662000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-328000
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1440000
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4129000
CY2023 hgbl Increase Decrease Of Payables To Sellers
IncreaseDecreaseOfPayablesToSellers
1787000
CY2022 hgbl Increase Decrease Of Payables To Sellers
IncreaseDecreaseOfPayablesToSellers
-3263000
CY2023 hgbl Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-625000
CY2022 hgbl Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-513000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
13021000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6483000
CY2023 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
29826000
CY2022 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
8435000
CY2023 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
11876000
CY2022 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
3446000
CY2023 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
17224000
CY2022 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
14612000
CY2023 hgbl Return Of Investment In Equity Method Investments
ReturnOfInvestmentInEquityMethodInvestments
9652000
CY2022 hgbl Return Of Investment In Equity Method Investments
ReturnOfInvestmentInEquityMethodInvestments
5309000
CY2023 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
1059000
CY2022 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
6991000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
257000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
215000
CY2023 hgbl Cash Received On Transfer Of Notes Receivable To Partners
CashReceivedOnTransferOfNotesReceivableToPartners
8851000
CY2022 hgbl Cash Received On Transfer Of Notes Receivable To Partners
CashReceivedOnTransferOfNotesReceivableToPartners
0
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15869000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7516000
CY2023 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
13000000
CY2022 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
2880000
CY2023 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
10054000
CY2022 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
2429000
CY2023 hgbl Proceeds From Issuance Of Common Stock From Stock Option Awards
ProceedsFromIssuanceOfCommonStockFromStockOptionAwards
36000
CY2022 hgbl Proceeds From Issuance Of Common Stock From Stock Option Awards
ProceedsFromIssuanceOfCommonStockFromStockOptionAwards
66000
CY2023 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
122000
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
44000
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
400000
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
395000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2460000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
78000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-388000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-955000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12667000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13622000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12279000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12667000
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
848000
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
297000
CY2023 us-gaap Interest Paid Net
InterestPaidNet
411000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
103000
CY2023 hgbl Noncash Change In Right Of Use Assets
NoncashChangeInRightOfUseAssets
405000
CY2022 hgbl Noncash Change In Right Of Use Assets
NoncashChangeInRightOfUseAssets
630000
CY2023 hgbl Noncash Change In Lease Liabilities
NoncashChangeInLeaseLiabilities
405000
CY2022 hgbl Noncash Change In Lease Liabilities
NoncashChangeInLeaseLiabilities
630000
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of estimates</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><br/></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of the Company’s consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Management bases its estimates and judgments on historical experience and various other factors that are believed to be reasonable under the circumstances. Actual results could differ from those estimates.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Significant estimates include the assessment of collectability of revenue recognized and the valuation of accounts receivable and notes receivable, inventory, investments, goodwill and intangible assets, liabilities, deferred income tax assets and liabilities including projecting future years’ taxable income, and stock-based compensation. These estimates have the potential to significantly impact our consolidated financial statements, either because of the significance of the financial statement item to which they relate, or because they require judgment and estimation due to the uncertainty involved in measuring, at a specific point in time, events that are continuous in nature.<br/></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Specialty Lending - Concentration and credit risk</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of December 31, 2023, the Company held a gross balance of investments in notes receivable of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">38.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, recorded in both notes receivable and equity method investments. The Company's portfolio includes one borrower’s notes receivable balance of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">23.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, representing </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">62</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the Company's total notes receivable balance as of December 31, 2023, down from </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">82</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% as of December 31, 2022. The Company does not intend to hold highly concentrated balances due from any one borrower as part of its long-term strategy but will in the short term have concentration risk on its path to an established and more diversified portfolio.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company does not evaluate concentration risk solely based on balance due from specific borrowers, but also considers the number of portfolio purchases, type of charged off accounts within the portfolio, and the seller of the portfolio when determining the overall risk. Of the balance due from one borrower of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">23.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, there are </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">11</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> distinct loan agreements. The underlying portfolio of accounts are diversified throughout FinTech loans, installment loans and credit card accounts, and further diversified amongst six separate sellers of these charged off portfolios.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company mitigates this concentration risk by requiring, and monitoring, security from each borrower consisting of their charged off and nonperforming receivable portfolios. The Company engages in a due diligence process that leverages its valuation expertise and knowledge in the underlying nonperforming receivable portfolios marketplace. In the event of default, the Company is entitled to call the unpaid interest and principal balances and receive all net collections directly. The Company may also recover its investment by engaging a third party to collect on the underlying charged off or nonperforming receivable portfolio or the underlying portfolio can be sold through the Company's Brokerage segment. In certain cases, the Company’s recovery options may be subject to concurrence of the originator or other prior holder of the assets.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">From inception of the specialty lending program through December 31, 2023, the Company has incurred no actual credit losses.</span></p>
CY2023Q4 us-gaap Long Term Investments And Receivables Net
LongTermInvestmentsAndReceivablesNet
38400000
CY2023Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
23800000
CY2023 hgbl Borrowers Note Balance Percentage
BorrowersNoteBalancePercentage
0.62
CY2022 hgbl Borrowers Note Balance Percentage
BorrowersNoteBalancePercentage
0.82
CY2023Q4 hgbl Due From Borrower
DueFromBorrower
23800000
CY2023 hgbl Number Of Distinct Portfolio Purchases And Loan Agreements
NumberOfDistinctPortfolioPurchasesAndLoanAgreements
11
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
51600000
CY2023Q4 hgbl Percentage Of Amortization Cost
PercentageOfAmortizationCost
0.59
CY2023Q4 us-gaap Loans And Leases Receivable Gain Loss On Sales Net
LoansAndLeasesReceivableGainLossOnSalesNet
8400000
CY2023Q4 us-gaap Debt Securities Held To Maturity Maturity After One Through Five Years Weighted Average Yield
DebtSecuritiesHeldToMaturityMaturityAfterOneThroughFiveYearsWeightedAverageYield
0.015
us-gaap Financing Receivable Allowance For Credit Loss Loan Purchased
FinancingReceivableAllowanceForCreditLossLoanPurchased
1000000
CY2023 us-gaap Financing Receivable Allowance For Credit Loss Loan Purchased
FinancingReceivableAllowanceForCreditLossLoanPurchased
1100000
CY2023 us-gaap Loans And Leases Receivable Gain Loss On Sales Net
LoansAndLeasesReceivableGainLossOnSalesNet
400000
CY2023Q4 hgbl Accrued Interest
AccruedInterest
200000
CY2022Q4 hgbl Accrued Interest
AccruedInterest
100000
CY2023Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
700000
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
600000
CY2023 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
100000
CY2023 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2022 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
9400000
CY2023 us-gaap Deferred Taxes Business Combination Valuation Allowance Available To Reduce Income Tax Expense
DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIncomeTaxExpense
2200000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
9100000
CY2023 us-gaap Revenue Recognition Sales Of Services
RevenueRecognitionSalesOfServices
<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Cost of services revenue and asset sales</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cost of services revenue generally includes the direct costs associated with generating commissions and fees from the Company’s auction and appraisal services, merger and acquisition advisory services, and brokering of charged-off receivable portfolios. The Company recognizes these expenses in the period in which the revenue they relate to is recorded. Cost of asset sales generally includes the cost of purchased inventory and the related direct costs of selling inventory. The Company recognizes these expenses in the period in which title to the inventory passes to the buyer, and the buyer assumes the risk and reward of the inventory.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2023Q4 hgbl Impaired Financing Receivables Unpaid Principal Balance
ImpairedFinancingReceivablesUnpaidPrincipalBalance
17500000
CY2023 us-gaap Notes Issued1
NotesIssued1
21000000
CY2023 us-gaap Proceeds From Sale Of Notes Receivable
ProceedsFromSaleOfNotesReceivable
11900000
CY2022Q4 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
100000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
700000
CY2022Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
9161000
CY2021Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
4172000
CY2023 hgbl Origination Of Notes Receivable
OriginationOfNotesReceivable
29826000
CY2022 hgbl Origination Of Notes Receivable
OriginationOfNotesReceivable
8435000
CY2023 hgbl Transfer Of Notes To And From Senior Lender
TransferOfNotesToAndFromSeniorLender
-8851000
CY2022 hgbl Transfer Of Notes To And From Senior Lender
TransferOfNotesToAndFromSeniorLender
0
CY2023 hgbl Principal Payment Of Note Receivable
PrincipalPaymentOfNoteReceivable
11876000
CY2022 hgbl Principal Payment Of Note Receivable
PrincipalPaymentOfNoteReceivable
3446000
CY2023Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
18260000
CY2022Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
9161000
CY2023 hgbl Deferred Finance Fees And Costs Net
DeferredFinanceFeesAndCostsNet
-139000
CY2022 hgbl Deferred Finance Fees And Costs Net
DeferredFinanceFeesAndCostsNet
-411000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
-650000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
0
CY2023Q4 us-gaap Notes Receivable Net
NotesReceivableNet
17471000
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
8750000
CY2023 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
500000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
700000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2023Q4 hgbl Credit Loss Reserve Rate
CreditLossReserveRate
0.036
CY2023Q4 hgbl Reserve For Credit Losses To Notes Receivable
ReserveForCreditLossesToNotesReceivable
0
CY2019Q2 us-gaap Sale Leaseback Transaction Date
SaleLeasebackTransactionDate
The purchase option for both the real estate and machinery and equipment could be exercised at any time on or after December 1, 2019, and before May 31, 2021,
CY2019Q2 us-gaap Sale Leaseback Transaction Net Book Value
SaleLeasebackTransactionNetBookValue
20000000
CY2023 us-gaap Convertible Preferred Stock Terms Of Conversion
ConvertiblePreferredStockTermsOfConversion
the Company’s shares of Series N preferred stock, each of which is convertible to 40 common shares, have the right to receive dividends or dividend equivalents should the Company declare dividends on its common stock.
CY2023Q4 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
40
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36677098
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36016619
CY2023 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
910210
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1080651
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37587308
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37097270
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
800000
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
800000
CY2023 hgbl Number Of Locations
NumberOfLocations
4
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
391000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
263000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
186000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
33000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
33000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
412000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2539000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2776000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2648000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2867000
CY2019Q1 hgbl Lessee Operating Lease Incremental Borrowing Rate
LesseeOperatingLeaseIncrementalBorrowingRate
0.0525
CY2022Q3 hgbl Lessee Operating Lease Incremental Borrowing Rate
LesseeOperatingLeaseIncrementalBorrowingRate
0.055
CY2023Q2 hgbl Lessee Operating Lease Incremental Borrowing Rate
LesseeOperatingLeaseIncrementalBorrowingRate
0.0725
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y1M6D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0535
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
800000
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
700000
CY2023Q4 hgbl Cash Paid For Operating Leases
CashPaidForOperatingLeases
800000
CY2022Q4 hgbl Cash Paid For Operating Leases
CashPaidForOperatingLeases
800000
CY2023Q4 hgbl Short Term Or Variable Leases
ShortTermOrVariableLeases
0
CY2022Q4 hgbl Short Term Or Variable Leases
ShortTermOrVariableLeases
0
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
781000
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
681000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
789000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
660000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
649000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
543000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
299000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2940000
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
292000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2648000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2051000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1789000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
346000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
218000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1705000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1571000
CY2023 us-gaap Depreciation
Depreciation
100000
CY2022 us-gaap Depreciation
Depreciation
100000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1707000
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
391000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1316000
CY2022Q4 hgbl Intangible Assets Net Excluding Goodwill One
IntangibleAssetsNetExcludingGoodwillOne
4144000
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
391000
CY2023Q4 hgbl Intangible Assets Net Excluding Goodwill One
IntangibleAssetsNetExcludingGoodwillOne
3753000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2128000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
421000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1707000
CY2021Q4 hgbl Intangible Assets Net Excluding Goodwill One
IntangibleAssetsNetExcludingGoodwillOne
4565000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
421000
CY2022Q4 hgbl Intangible Assets Net Excluding Goodwill One
IntangibleAssetsNetExcludingGoodwillOne
4144000
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
400000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
400000
CY2023Q4 us-gaap Acquired Finite Lived Intangible Asset Residual Value
AcquiredFiniteLivedIntangibleAssetResidualValue
0
CY2022Q4 hgbl Finite Lived Intangible Asset Net
FiniteLivedIntangibleAssetNet
1316000
CY2023Q4 us-gaap Goodwill
Goodwill
7446000
CY2022Q4 us-gaap Goodwill
Goodwill
7446000
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
100000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4423000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4660000
CY2023Q4 hgbl Accrued Asset Liquidation Expenses
AccruedAssetLiquidationExpenses
705000
CY2022Q4 hgbl Accrued Asset Liquidation Expenses
AccruedAssetLiquidationExpenses
2573000
CY2023Q4 hgbl Due To Joint Venture Partners Current
DueToJointVenturePartnersCurrent
638000
CY2022Q4 hgbl Due To Joint Venture Partners Current
DueToJointVenturePartnersCurrent
793000
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
497000
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
279000
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
626000
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
220000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
189000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
204000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
159000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
195000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
7237000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
8924000
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-2205000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2224000
CY2022Q4 hgbl Additional Deferred Tax Assets Realizable Amount
AdditionalDeferredTaxAssetsRealizableAmount
7100000
CY2023Q4 hgbl Additional Deferred Tax Assets Realizable Amount
AdditionalDeferredTaxAssetsRealizableAmount
2200000
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
50000000
CY2023 hgbl Operating Loss Carryforwards Expiration
OperatingLossCarryforwardsExpiration
These net operating loss carry forwards begin to expire in 2024.
CY2020 us-gaap Open Tax Year
OpenTaxYear
2020
CY2022 us-gaap Open Tax Year
OpenTaxYear
2022
CY2023Q4 us-gaap Unsecured Debt Current
UnsecuredDebtCurrent
1733000
CY2022Q4 us-gaap Unsecured Debt Current
UnsecuredDebtCurrent
3411000
CY2023Q4 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
5495000
CY2022Q4 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
871000
CY2023Q4 us-gaap Loans Payable
LoansPayable
7228000
CY2022Q4 us-gaap Loans Payable
LoansPayable
4282000
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations Repayments Of Principal In Next Twelve Months
LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths
1733000
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo
1732000
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree
1460000
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Four
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour
1595000
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Five
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive
708000
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
7228000
CY2014Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
12242000
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-7813000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4429000
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
2939000
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
2311000
CY2023 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
996000
CY2022 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
470000
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-196000
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-179000
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-2205000
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-7813000
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-14000
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
725000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1520000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4486000
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
11012000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
14097000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
348000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
317000
CY2023Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
224000
CY2022Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
0
CY2023Q4 hgbl Deferred Tax Assets Operating Lease Liability
DeferredTaxAssetsOperatingLeaseLiability
628000
CY2022Q4 hgbl Deferred Tax Assets Operating Lease Liability
DeferredTaxAssetsOperatingLeaseLiability
742000
CY2023Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
239000
CY2022Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
0
CY2023Q4 hgbl Deferred Tax Assets Allowance For Credit Loss
DeferredTaxAssetsAllowanceForCreditLoss
176000
CY2022Q4 hgbl Deferred Tax Assets Allowance For Credit Loss
DeferredTaxAssetsAllowanceForCreditLoss
0
CY2023Q4 hgbl Deferred Tax Assets Accruals
DeferredTaxAssetsAccruals
131000
CY2022Q4 hgbl Deferred Tax Assets Accruals
DeferredTaxAssetsAccruals
0
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
137000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
280000
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
12895000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
15436000
CY2023Q4 us-gaap Deferred Tax Liabilities Investments
DeferredTaxLiabilitiesInvestments
28000
CY2022Q4 us-gaap Deferred Tax Liabilities Investments
DeferredTaxLiabilitiesInvestments
0
CY2023Q4 hgbl Deferred Tax Liabilities Operating Lease Right Of Use Asset
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset
-599000
CY2022Q4 hgbl Deferred Tax Liabilities Operating Lease Right Of Use Asset
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset
-718000
CY2023Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
173000
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
127000
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1556000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1558000
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
11339000
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
13878000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2224000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4429000
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
9115000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
9449000
CY2023 hgbl Reduction In Deferred Tax Assets
ReductionInDeferredTaxAssets
4400000
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4400000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
10
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
25000
CY2023Q4 hgbl Preferred Stock Conversion Price Per Share
PreferredStockConversionPricePerShare
1000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
4
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
102125
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
339125
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.04
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.02
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.03
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.65
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.70
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2027350
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.38
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2193288
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.23
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
470000
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.91
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
279500
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.62
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
102125
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.86
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
339125
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.5
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
129875
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.72
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
106313
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.79
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2265350
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.71
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2027350
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.38
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1275225
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.02
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1023975
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.97
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.91
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.62
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
990125
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
2.38
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1003375
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.8
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1400000
CY2023 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y8M12D
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
600000
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
700000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2265350
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1275225
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2000000
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1500000

Files In Submission

Name View Source Status
0000950170-24-031436-index-headers.html Edgar Link pending
0000950170-24-031436-index.html Edgar Link pending
0000950170-24-031436.txt Edgar Link pending
0000950170-24-031436-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hgbl-20231231.htm Edgar Link pending
hgbl-20231231.xsd Edgar Link pending
hgbl-ex10_25.htm Edgar Link pending
hgbl-ex10_26.htm Edgar Link pending
hgbl-ex10_27.htm Edgar Link pending
hgbl-ex10_28.htm Edgar Link pending
hgbl-ex10_29.htm Edgar Link pending
hgbl-ex10_34.htm Edgar Link pending
hgbl-ex10_35.htm Edgar Link pending
hgbl-ex10_36.htm Edgar Link pending
hgbl-ex10_44.htm Edgar Link pending
hgbl-ex21.htm Edgar Link pending
hgbl-ex23_1.htm Edgar Link pending
hgbl-ex31_1.htm Edgar Link pending
hgbl-ex31_2.htm Edgar Link pending
hgbl-ex32_1.htm Edgar Link pending
hgbl-ex32_2.htm Edgar Link pending
hgbl-ex97_1.htm Edgar Link pending
img15146307_0.jpg Edgar Link pending
img161594754_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
hgbl-20231231_htm.xml Edgar Link completed
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable